CHRONIC MIGRAINE
Clinical trials for CHRONIC MIGRAINE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MIGRAINE trials appear
Sign up with your email to follow new studies for CHRONIC MIGRAINE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to cut teen migraines in half
Disease control OngoingThis study is testing whether a monthly injection called galcanezumab can safely reduce the number of migraine days for teenagers with chronic migraine. About 312 participants aged 12 to 17 will receive either the real medicine or a placebo (dummy shot) for 3 months, followed by …
Matched conditions: CHRONIC MIGRAINE
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New shot could cut migraine days in half for sufferers
Disease control OngoingThis study is testing whether regular injections of Dysport, a medication similar to Botox, can safely reduce the number of migraine days for adults with chronic migraines. About 759 participants will receive either Dysport or a placebo shot in their head, neck, and shoulders ove…
Matched conditions: CHRONIC MIGRAINE
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Italian study tests daily pill to tame debilitating migraines
Disease control OngoingThis study is observing how well a daily medication called atogepant works to prevent migraine attacks in real-world settings. It will follow 500 people in Italy with episodic or chronic migraines for up to two years, tracking how many headache days they have and how the treatmen…
Matched conditions: CHRONIC MIGRAINE
Sponsor: University of Florence • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Remote mindset training could ease debilitating migraine suffering
Symptom relief OngoingThis study is testing whether two brief, remote behavioral programs can help adults with chronic migraine reduce their headache-related disability and symptom severity. 300 participants will be randomly assigned to either an 'Empowered Relief' program, a health education program,…
Matched conditions: CHRONIC MIGRAINE
Phase: NA • Sponsor: University of Michigan • Aim: Symptom relief
Last updated Mar 02, 2026 15:22 UTC